| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020680 |
| Receipt No. | R000023863 |
| Official scientific title of the study | The effects of sevoflurane on the QT interval in patients with diabetes |
| Date of disclosure of the study information | 2016/01/21 |
| Last modified on | 2018/02/01 (Ver. 10) |
| Basic information | ||
| Official scientific title of the study | The effects of sevoflurane on the QT interval in patients with diabetes | |
| Title of the study (Brief title) | The effects of sevoflurane on the QT interval in patients with diabetes | |
| Region |
|
|
| Condition | |||
| Condition | diabetes | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The purpose of this study is to investigate the effects on the ECG QT interval by sevoflurane in diabetes |
| Basic objectives2 | Pharmacodynamics |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | ECG QTc interval
Sevoflurane administration before and After administration, 5 minutes, 10 minutes, 30 minutes, 60 minutes, 90 minutes, 120 minutes |
| Key secondary outcomes | ECG Tp-e interval
Sevoflurane administration before and After administration, 5 minutes, 10 minutes, 30 minutes, 60 minutes, 90 minutes, 120 minutes |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | general anesthetic patient | |||
| Key exclusion criteria | Heart surgery
Pregnant woman Atrial fibrillation Bundle branch block |
|||
| Target sample size | 74 | |||
| Research contact person | |
| Name of lead principal investigator | Seishi Kimura |
| Organization | Kindai University Faculty of Medicine |
| Division name | Department of Anesthesiology |
| Address | 377-2 Ohno-higashi, Osaka-sayama 589-8511, Japan |
| TEL | 072-366-0221 |
| s-kimura@med.kindai.ac.jp | |
| Public contact | |
| Name of contact person | Seishi Kimura |
| Organization | Kindai University Faculty of Medicine |
| Division name | Department of Anesthesiology |
| Address | 377-2 Ohno-higashi, Osaka-sayama 589-8511, Japan |
| TEL | 072-366-0221 |
| Homepage URL | |
| s-kimura@med.kindai.ac.jp | |
| Sponsor | |
| Institute | Department of Anesthesiology, Kindai University Faculty of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Anesthesiology, Kindai University Faculty of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 近畿大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0188555 |
| Results | In the hyperglycemic group, the QTc interval is extended, but the Tp - ec interval is not prolonged. |
| Other related information | We enrolled normoglycemic patients (HbA1c: <6.5%) (NG group) and chronically hyperglycemic patients (HbA1c: >=6.5%) (HG group). The QT interval and Tp-e interval (from the peak to the end of the T wave were measured before and at 5, 10, 30, 60, 90, and 120 min after sevoflurane administration, and corrected for the RR interval using Bazett's formula (QTc and Tp-ec)
This research is a prospective study. Those subjects who underwent surgery at the institution starting January 2016 were eligible for selection criteria. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023863 |